AI pharma startup Basecamp raises $140M from Nvidia, Rockefeller, NATO

Basecamp, an AI-driven pharmaceutical company, closed a $140 million funding round at an $800 million valuation, with participation from Nvidia, the Rockefeller Foundation, and NATO's innovation fund. The involvement of NATO's venture arm signals strategic interest in AI for defense-related health applications, though the commercial and strategic implications remain unclear.